Brodsky & Smith LLC is investigating claims against the Board of Directors of InMed Pharmaceuticals regarding potential breaches of fiduciary duty in the company's sale to Mentari Therapeutics. The investigation questions whether the board conducted a fair process and if shareholders are receiving fair value, as InMed shareholders will own about 1.51% of the combined company. Shareholders are encouraged to contact the law firm for legal advice or questions. This could impact shareholder rights and the valuation of the transaction.
Webull Corp. has introduced Vega Analyst, an AI-powered research tool that provides customized, real-time stock analysis based on user-selected research areas like fundamentals, valuation, and technical trends. This tool helps investors better unders...
Brady Corporation announced a regular dividend of $0.245 per share for its Class A Common Stock. The dividend will be paid on July 31, 2026, to shareholders of record as of July 10, 2026. This move reflects Brady's ongoing commitment to returning val...
Halper Sadeh LLC is investigating whether shareholders of LiveRamp, Dominion Energy, Sachem Capital, and NextEra Energy are receiving fair deals in their companies' recent mergers and acquisitions. The firm suspects insiders may gain financial benefi...
Aura Biosciences announced inducement equity awards for its new CEO and President, Natalie Holles, including stock options, restricted stock units (RSUs), and performance-based RSUs (PRSUs). These awards, approved under Nasdaq Listing Rule 5635(c)(4)...
Farmers and Merchants Bancshares, Inc. announced a 5.9% increase in its cash dividend to $0.36 per share, payable on June 18, 2026, to shareholders of record as of June 2, 2026. This dividend hike reflects the company's strong financial position and ...
